Judgment of the Court (Third Chamber) of 12 December 2013.
Eli Lilly and Company Ltd v Human Genome Sciences Inc.
Reference for a preliminary ruling: High Court of Justice (England & Wales), Chancery Division (Patents Court) - United Kingdom.
Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Article 3 - Conditions for obtaining such a certificate - Concept of a ‘product protected by a basic patent in force’ - Criteria - Wording of the claims of the basic patent - Precision and specificity - Functional definition of an active ingredient - Structural definition of an active ingredient - European Patent Convention.
Reports of Cases
not yet published (Court Reports - general)
Links to the texts